14
Jun
2022
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
13.05.2022
voting rights
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
11.05.2022
voting rights
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
09.05.2022
voting rights
16
Jun
2022
The JMP Securities Life Sciences Conference (New York City)
Jean-Paul Kress, M.D. (CEO) presents the Company at the JMP Securities Life Sciences Conference on June 16, 2022 9:30 – 9:55 a.m. EST / 3:30 – 3:55 p.m. CEST.
To the Webcast.